Login  
HSRO Home


Search

 Go
Advanced Search


Investigator Resources

Information for Research Participants
Information for Study Teams
Information for Sponsors
Institutional Review Boards
UM Policies & Procedures - HSRO/IRB
1. Preface
2. Background Topics
3. Authorities and Responsibilities
4. Conflict of Interest
5. Institutional Review Boards
6. IRB Meetings
7. General Principles for IRB Reviews
8. Definition of IRB Review Types
9. IRB Review of Initial Studies
10. IRB Review of Continuing Studies
11. Amendments
12. Closing Studies and Final Reports
13. Suspension, Termination and Administrative Closure of IRB Approved Research
14. Unanticipated Problems and Adverse Events
15. Study Violations
16. Compliance Audits
17. Data Safety Monitoring Boards
18. Ancillary Committees
19. External IRB's
20. Policies Specific to Certain Types of Research
21. Informed Consent
22. Participant Recruitment Methods, Advertising Materials and Recruitment-Relevant Payment Arrangements
23. Vulnerable Populations
24. Privacy, Security, Confidentiality and HIPAA
25. Subcontracts/Agreements for UM-Initiated Studies that Engage or Involve non-UM Institutions or Investigators
26. International Research
27. Emergency Use
28. Record Retention
Other Policies
UChart Forms & Guidance
HSRO Forms & Documents
University Fees
Ancillary Committee Information
eProst User Guide
Ethics, Federal Regulations & Guidance
HIPAA
Translations
Western IRB (WIRB)
About the HSRO


Basic Folder Information

26.2 Engaged in UM-Research


Approval Date

Review Responsibility:

IRB Policy and Procedure Committee

Current Approval Date:

March 7, 2007



26.2 Engaged in UM-Research

When a foreign institution, site and/or investigator is to be ‘engaged” in UM human subject research, the following policies apply: 

1)  The research requires review and approval by the UM IRB

2)  The UM IRB may approve the study if the foreign entity's procedures afford protections of the rights and welfare of the participants that are at least equivalent to those provided in 45 CFR 46, 21 CFR 50, 21 CFR 56 and the written policies of the UM IRB and if the resources and facilities are appropriate for the research.

3)  The foreign institution or site must hold an FWA ("Federal Wide Assurance") approved by the U.S. Department of Health and Human Services (DHHS),   Office for Human Research Protections (OHRP) affirming that it is in compliance with DHHS regulations contained within 45 CFR 46, 21 CFR 50, and 21 CFR 56.

4)  As part of its review/approval process, the UM IRB must receive and review the foreign institution or site’s IRB or Independent Ethics Committee (IEC (or equivalent) review and approval of the study [NOTE – An IEC is a specially constituted review body responsible to ensure the protection of the rights, welfare and safety of research participants. An IEC shares the same composition and operations as an Institutional Review Board at a foreign site]

5)  As part of its review/approval process, the UM IRB must review all subcontracts or other agreements between UM and the foreign entity and/or investigator

6)  UM IRB approval is contingent upon documentation of foreign governmental approvals as applicable.

7)  The study may not commence at the foreign entity or by the foreign investigator prior to UM IRB approval



Footer Block

University of Miami Office of Research UM School of Medicine CITI Program Jackson Health System
 University of Miami logo University of Miami
Human Subjects Research Office

1500 NW 12th Avenue, Ste. 1002, Miami, FL 33136
Tel. 305-243-3195
Copyright, University of Miami, All Rights Reserved
Requests for information. Send technical feedback.
View Privacy statement